Antiviral potential and molecular insight into neuraminidase inhibiting diarylheptanoids from Alpinia katsumadai

J Med Chem. 2010 Jan 28;53(2):778-86. doi: 10.1021/jm901440f.


At present, neuraminidase (NA) inhibitors are the mainstay of pharmacological strategies to fight against global pandemic influenza. In the search for new antiviral drug leads from nature, the seed extract of Alpinia katsumadai has been phytochemically investigated. Among the six isolated constituents, four diarylheptanoids showed in vitro NA inhibitory activities in low micromolar ranges against human influenza virus A/PR/8/34 of subtype H1N1. The most promising constituent, katsumadain A (4; IC(50) = 1.05 +/- 0.42 microM), also inhibited the NA of four H1N1 swine influenza viruses, with IC(50) values between 0.9 and 1.64 muM, and showed antiviral effects in plaque reduction assays. Considering the flexible loop regions of NA, extensive molecular dynamics (MD) simulations were performed to study the putative binding mechanism of the T-shaped diarylheptanoid 4. Docking results showed well-established interactions between the protein and the core of this novel NA-inhibiting natural scaffold, excellent surface complementarity to the simulated binding pocket, and concordance with experimentally derived SAR data.

MeSH terms

  • Alpinia / chemistry*
  • Antiviral Agents / isolation & purification
  • Antiviral Agents / pharmacology*
  • Diarylheptanoids / isolation & purification
  • Diarylheptanoids / pharmacology*
  • Humans
  • Influenza A Virus, H1N1 Subtype / drug effects*
  • Inhibitory Concentration 50
  • Molecular Dynamics Simulation
  • Neuraminidase / antagonists & inhibitors*
  • Phytotherapy
  • Plants, Medicinal / chemistry
  • Protein Binding
  • Structure-Activity Relationship


  • Antiviral Agents
  • Diarylheptanoids
  • Neuraminidase